Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Brenton

Showing results (131-140 of 229) with videos related to

Pageof 23
Sort By:
Plos Medicine|February 25, 2015
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysisRoland F Schwarz, Charlotte K Y Ng, Susanna L Cooke, et al.
Cancer Cell|December 11, 2007
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxelAhmed Ashour Ahmed, Anthony D Mills, Ashraf E K Ibrahim, et al.
Oncogene|September 27, 2006
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancersS-F Chin, Y Wang, N P Thorne, et al.
Genome Biology|October 11, 2007
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancerSuet F Chin, Andrew E Teschendorff, John C Marioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2017
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trialH R Ali, A Dariush, J Thomas, et al.
Breast Cancer Research : BCR|February 18, 2016
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancerH Raza Ali, Aliakbar Dariush, Elena Provenzano, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.
Nature|December 10, 2025
Somatic evolution following cancer treatment in normal tissueOriol Pich, Sophia Ward, Andrew Rowan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2024
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United KingdomElaine Yl Leung, Shibani Nicum, Jo Morrison, et al.
European Radiology|December 14, 2020
Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancerLucian Beer, Paula Martin-Gonzalez, Maria Delgado-Ortet, et al.
Pageof 23

Showing results (131-140 of 229) with videos related to

Sort By:
Pageof 23
Plos Medicine|February 25, 2015
Spatial and temporal heterogeneity in high-grade serous ovarian cancer: a phylogenetic analysisRoland F Schwarz, Charlotte K Y Ng, Susanna L Cooke, et al.
Cancer Cell|December 11, 2007
The extracellular matrix protein TGFBI induces microtubule stabilization and sensitizes ovarian cancers to paclitaxelAhmed Ashour Ahmed, Anthony D Mills, Ashraf E K Ibrahim, et al.
Oncogene|September 27, 2006
Using array-comparative genomic hybridization to define molecular portraits of primary breast cancersS-F Chin, Y Wang, N P Thorne, et al.
Genome Biology|October 11, 2007
High-resolution aCGH and expression profiling identifies a novel genomic subtype of ER negative breast cancerSuet F Chin, Andrew E Teschendorff, John C Marioni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 20, 2017
Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trialH R Ali, A Dariush, J Thomas, et al.
Breast Cancer Research : BCR|February 18, 2016
Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancerH Raza Ali, Aliakbar Dariush, Elena Provenzano, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2009
Chromosomal instability determines taxane responseCharles Swanton, Barbara Nicke, Marion Schuett, et al.
Nature|December 10, 2025
Somatic evolution following cancer treatment in normal tissueOriol Pich, Sophia Ward, Andrew Rowan, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 2, 2024
British Gynaecological Cancer Society/British Association of Gynaecological Pathology consensus for genetic testing in epithelial ovarian cancer in the United KingdomElaine Yl Leung, Shibani Nicum, Jo Morrison, et al.
European Radiology|December 14, 2020
Ultrasound-guided targeted biopsies of CT-based radiomic tumour habitats: technical development and initial experience in metastatic ovarian cancerLucian Beer, Paula Martin-Gonzalez, Maria Delgado-Ortet, et al.
Pageof 23